1231925-89-5

Basic information

• Product Name: 4-(3-(2-methoxypyridin-3-yl)pyrazin-2-yloxy)aniline
• Synonyms: 4-(3-(2-methoxypyridin-3-yl)pyrazin-2-yloxy)aniline
• CAS NO: 1231925-89-5
• Molecular Weight: 294.313
• Mol File: 1231925-89-5.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: 4-(3-(2-methoxypyridin-3-yl)pyrazin-2-yloxy)aniline(CAS DataBase Reference)
• NIST Chemistry Reference: 4-(3-(2-methoxypyridin-3-yl)pyrazin-2-yloxy)aniline(1231925-89-5)
• EPA Substance Registry System: 4-(3-(2-methoxypyridin-3-yl)pyrazin-2-yloxy)aniline(1231925-89-5)

Safety Data

• Hazardous Substances Data: 1231925-89-5(Hazardous Substances Data)

Upstream product

• 105130-25-4 4-(3-chloropyrazin-2-yloxy)benzenamine 
• 532391-31-4 2-methoxy-3-(4,4,5,5-tetramethyl-[1,3,2]dioxaborolan-2-yl)pyridine 

Downstream Products

• 1231923-29-7 N-(4-(3-(2-methoxypyridin-3-yl)pyrazin-2-yloxy)phenyl)pyridine-2-amine 

Relevant articles and documents

AMINOPYRIDINE AND CARBOXYPYRIDINE COMPOUNDS AS PHOSPHODIESTERASE 10 INHIBITORS

Pyridine and pyrimidine compounds: or a pharmaceutically acceptable salt thereof, wherein m, n, R1, R2, R3, R4, R5, R6, R7, X1, X2, X3, X4, X5, X6, X7, X8, and Y are as defined in the specification; or a pharmaceutically acceptable salt thereof, wherein ring A, m, n, y, R2, R3, R4, R5, R6, R7, R8, R9, X1, X2, and ring A are as defined in the specification; and or a pharmaceutically acceptable salt thereof, wherein m, n, y, R2, R3, R4, R5, R6, R7, R9, X1, X2, and ring A are as defined in the specification; compositions containing them, and processes for preparing such compounds. Provided herein also are methods of treating disorders or diseases treatable by inhibition of PDE10, such as obesity, non-insulin dependent diabetes, schizophrenia, bipolar disorder, obsessive-compulsive disorder, and the like.